Cell Harvesting System Market Size & Growth Forecast 2027–2036, By Segments (Application, End-use, Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Cell Harvesting System Market size was more than USD 7.6 billion in 2026 and is set to grow at a 13.68% CAGR between 2027 and 2036, reaching USD 27.39 billion by 2036. The industry revenue for 2027 is assessed at USD 8.48 billion.
Get more details on this report
Request Free Sample ReportCell Harvesting System Market Intelligence Snapshot
Regional Market Dynamics
- North America led the market in 2026, supported by a mature biopharmaceutical ecosystem, advanced research institutions, and commercial manufacturing activities requiring reliable, scalable cell harvesting technologies.
- Asia Pacific is expected to expand at a 15.9% CAGR, driven by biomanufacturing infrastructure expansion, rising regenerative medicine investments, and growing adoption of automated cell harvesting platforms.
Segment Momentum
- Peripheral Blood accounted for 33.28% of the market in 2026 due to its ease of collection, established clinical use, and compatibility with routine therapeutic and diagnostic workflows.
- R&D Centers are expanding rapidly as growing research in cell therapy and regenerative medicine increases demand for specialized harvesting systems supporting experimental and early-stage therapeutic development.
Market Expansion Drivers
- Rising investment in regenerative medicine and biopharmaceutical R&D accelerating advanced cell harvesting adoption.
- Increasing prevalence of chronic diseases and demand for stem cell therapies boosting clinical applications.
- Expansion of automated cryopreservation and bioprocessing technologies improving efficiency and scalability of cell collection systems.
Leading Market Participants
- Major companies in the cell harvesting system market include PerkinElmer Inc. (United States), BRAND GMBH + CO KG (Germany), Arthrex, Inc. (United States), Avita Medical, Inc. (Australia), Terumo Corporation (Japan), Teleflex Incorporated (United States), Bertin Technologies (France), Sartorius AG (Germany).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 7.6 billion
- 2027 Estimated Market Size: USD 8.48 billion.
- Projected Market Size: USD 27.39 billion by 2036
- Growth Forecast: 13.68% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Peripheral Blood (Application) | Hospital (End-use) | Automated (Type)
- Emerging Opportunity Segment: Adipose Tissue (Application) | R & D Centers (End-use) | Automated (Type)
Market Growth Drivers and Industry Trends
Rising investment in regenerative medicine and biopharmaceutical R&D accelerating advanced cell harvesting adoption
Growing investment in regenerative medicine and biopharmaceutical research is increasing the need for reliable methods to collect and process cells, supporting the cell harvesting system market as research moves toward more sophisticated cell-based applications. Cell harvesting represents an important stage in workflows involving cell therapies, biological research, and bioprocess development, where maintaining cell quality and minimizing processing losses are essential. Expansion of research programs is encouraging laboratories and biomanufacturing facilities to adopt systems capable of handling cell collection with greater consistency and process control. As cell-based approaches progress from research activities toward more structured development and manufacturing workflows, demand is increasing for harvesting technologies that can integrate efficiently with broader bioprocessing operations.
Increasing prevalence of chronic diseases and demand for stem cell therapies boosting clinical applications
The growing burden of chronic diseases and increasing interest in stem cell-based therapeutic approaches are expanding clinical activity involving cell collection, processing, and preparation, which will boost the cell harvesting system market demand. Stem cell therapies require controlled handling of biological materials throughout collection and processing, creating a need for systems that can support efficient recovery while preserving cell viability and quality. As healthcare research continues to explore cell-based approaches for conditions requiring regenerative or personalized treatment strategies, clinical and translational programs are generating greater requirements for dependable cell-processing infrastructure. The need to manage biological samples consistently across different stages of therapy development is also increasing the relevance of specialized harvesting equipment.
Expansion of automated cryopreservation and bioprocessing technologies improving efficiency and scalability of cell collection systems
Greater adoption of automated cryopreservation and advanced bioprocessing technologies is encouraging integration between cell collection and downstream processing workflows, strengthening the cell harvesting system market by improving operational efficiency and scalability. Automation can reduce manual intervention during repetitive processing steps, support more consistent handling conditions, and facilitate standardized workflows across research and manufacturing environments. Integration with cryopreservation systems also enables collected cells to be transferred into controlled storage and processing pathways with greater procedural consistency. As bioprocessing facilities seek scalable platforms capable of supporting increasingly complex cell-based workflows, automated harvesting technologies are becoming more closely aligned with requirements for process control, reproducibility, and efficient laboratory operations.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising investment in regenerative medicine and biopharmaceutical R&D accelerating advanced cell harvesting adoption | 2.40% | High | North America, Europe | High | Near Term |
| Increasing prevalence of chronic diseases and demand for stem cell therapies boosting clinical applications | 2.10% | High | North America, Asia Pacific | High | Near Term |
| Expansion of automated cryopreservation and bioprocessing technologies improving efficiency and scalability of cell collection systems | 1.90% | High | Europe, North America, Asia Pacific | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America maintained the largest position in the cell harvesting system market in 2026, supported by advanced biopharmaceutical manufacturing infrastructure, established cell and gene therapy capabilities, and strong adoption of automated processing technologies. Growing demand for scalable and reproducible cell-processing workflows is encouraging the use of specialized harvesting systems that improve process efficiency while supporting consistent product quality. Investment in bioprocessing facilities and increasing emphasis on automation, closed processing, and contamination control further strengthen the regional market environment.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing regional market as biopharmaceutical manufacturing capacity expands and healthcare investment increases across emerging and established markets. Growing development of cell-based therapies and biologics is creating greater demand for efficient downstream processing and cell recovery technologies. The establishment of modern biomanufacturing facilities, increasing technology adoption, and efforts to strengthen domestic pharmaceutical production are supporting broader deployment of automated cell harvesting systems across the region.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants/Startups i Scale Low Medium High | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Bioprocess Technology AdoptionGermany's strong biopharmaceutical research ecosystem supports demand for advanced cell harvesting systems used in regenerative medicine and biologics production. Laboratories and manufacturers in Germany are prioritizing automated platforms that improve reproducibility and reduce contamination risks.
France 🇫🇷
Translational Research InfrastructureFrance's cell harvesting system market benefits from ongoing investment in biomedical research centers and advanced therapy programs. Research organizations in France increasingly require systems that enable efficient cell recovery and support complex laboratory workflows.
Italy 🇮🇹
Clinical Research ApplicationsItaly is experiencing steady demand for cell harvesting systems across academic research and regenerative medicine initiatives. Healthcare and research institutions in Italy are focusing on technologies that improve cell viability and streamline sample processing procedures.
Japan 🇯🇵
Regenerative Medicine SupportJapan's focus on regenerative medicine and stem cell research is driving demand for precise and efficient cell harvesting technologies. Research institutions and biotechnology companies in Japan increasingly invest in systems that facilitate standardized cell processing workflows.
South Korea 🇰🇷
Biomanufacturing Capacity ExpansionSouth Korea is strengthening its biomanufacturing capabilities, creating demand for cell harvesting systems that support large-scale therapeutic production. Companies in South Korea are adopting automated solutions to improve process efficiency and accelerate clinical development activities.
United States 🇺🇸
Cell Therapy Manufacturing HubThe U.S. cell harvesting system market is expanding alongside investments in cell and gene therapy manufacturing infrastructure. Biopharmaceutical companies in the U.S. increasingly seek automated harvesting technologies that improve scalability, process control, and compliance requirements.
Segment Leadership and Growth Trends
Cell Harvesting System Market Share (%), by Application, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportApplication Segment Analysis: Peripheral Blood (Largest Segment) vs Adipose Tissue (Fastest-Growing Segment)
Peripheral blood segment held the largest share of the cell harvesting system market in 2026, accounting for 33.28% share, supported by its established role as an accessible source for cell collection across clinical and research applications. The relatively straightforward availability of peripheral blood and its relevance to cell-based workflows make it a widely used source material for harvesting procedures. Growing interest in cellular therapies, regenerative medicine, and laboratory-based cell processing is reinforcing demand for efficient systems that can support consistent collection and downstream processing. The need for reliable and controlled cell harvesting from readily accessible biological sources further sustains the segment's leading position.
Adipose tissue is emerging as the fastest-growing application segment, driven by increasing interest in adipose-derived cells for regenerative medicine and cell-based research. Adipose tissue provides a valuable source of cells with potential applications across therapeutic development and tissue-related research, encouraging greater attention to efficient harvesting techniques. As research and clinical activities increasingly explore alternative cellular sources, the need for systems capable of processing adipose tissue efficiently is expanding. Advances in cell-based applications and growing emphasis on scalable cell collection workflows are supporting the segment's rapid adoption.
End-use Segment Analysis: Hospital (Largest Segment) vs R & D Centers (Fastest-Growing Segment)
The hospital segment represented the largest end-use category in the cell harvesting system market in 2026, reflecting the growing integration of cell collection and processing procedures within clinical environments. Hospitals require dependable systems to support cell-based procedures, therapeutic workflows, and patient-oriented applications where efficient biological sample handling is essential. Increasing interest in regenerative medicine and advanced cellular therapies is encouraging healthcare facilities to strengthen their capabilities for cell processing. The need for controlled, reliable, and clinically suitable harvesting processes continues to underpin demand across hospital settings.
R & D centers are registering the fastest growth as research institutions expand investigations into cell biology, regenerative medicine, cellular therapies, and related applications. These facilities require flexible and efficient harvesting systems to support experimental workflows, sample preparation, and development of new cell-based approaches. Increasing research activity around alternative cellular sources and advanced processing techniques is creating greater demand for specialized equipment. The emphasis on improving research efficiency, reproducibility, and downstream cell analysis is further strengthening adoption across R & D centers.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Application | Umbilical Cord, Bone Marrow, Peripheral Blood, Adipose Tissue, Others | Peripheral Blood | Adipose Tissue |
| End-use | Hospital, Clinic, Academic Institutes, R & D Centers | Hospital | R & D Centers |
| Type | Manual, Automated | Automated | Automated |
Competitive Landscape and Market Positioning
Top players in the cell harvesting system market:
1. PerkinElmer Inc. (United States)
2. BRAND GMBH + CO KG (Germany)
3. Arthrex Inc. (United States)
4. Avita Medical Inc. (Australia)
5. Terumo Corporation (Japan)
6. Teleflex Incorporated (United States)
7. Bertin Technologies (France)
8. Sartorius AG (Germany)
The cell harvesting system market is evolving through advancements in bioprocessing efficiency and cell recovery precision. New system designs are being introduced to improve yield and process control. Research efforts are enhancing scalability and contamination reduction techniques. Collaborative innovation is also supporting progress in biopharmaceutical manufacturing workflows.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| PerkinElmer Inc. (United States) | |||||||
| BRAND GMBH + CO KG (Germany) | |||||||
| Arthrex Inc. (United States) | |||||||
| Avita Medical Inc. (Australia) | |||||||
| Terumo Corporation (Japan) | |||||||
| Teleflex Incorporated (United States) | |||||||
| Bertin Technologies (France) | |||||||
| Sartorius AG (Germany). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| AstraZeneca | Mar-25 | AstraZeneca acquired EsoBiotec for USD 425 million to strengthen its in vivo cell therapy portfolio. The acquisition expands the company's capabilities across advanced cell therapy development, supporting broader commercialization within the cell harvesting and processing ecosystem. |
| Thermo Fisher Scientific | Feb-25 | Thermo Fisher announced the USD 4.1 billion acquisition of Solventum's purification and filtration business. The transaction expands complementary bioproduction capabilities, strengthening manufacturing infrastructure supporting advanced cell therapy and biologics production. |
| Terumo Blood and Cell Technologies | Jan-25 | Terumo Blood and Cell Technologies partnered with FUJIFILM Irvine Scientific to combine the Quantum Flex platform with PRIME-XV media for rapid T-cell expansion. The collaboration enhances integrated workflows supporting scalable cell manufacturing and harvesting applications. |
| Sumitomo Chemical | Dec-24 | Sumitomo Chemical established RACTHERA to expand its regenerative medicine business, targeting approximately ¥350 billion in revenue by the late 2030s. The initiative represents a strategic investment in advanced cell therapy manufacturing and commercialization capabilities. |
| Terumo Blood and Cell Technologies | Mar-24 | Terumo Blood and Cell Technologies partnered with the CiRA Foundation to accelerate industrial adoption of induced pluripotent stem cell technologies. The collaboration supports development and commercialization of regenerative therapies by strengthening cell processing and manufacturing capabilities. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Cell Harvesting System Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Workflow Stage | Cell Isolation, Cell Washing & Concentration, Cell Separation & Purification |
| Scale of Operation | Research Scale, Preclinical/Process Development Scale, Clinical & Commercial Manufacturing Scale |
| Therapy Area | Cell Therapy, Regenerative Medicine, Cancer Immunotherapy, Stem Cell Applications |
Cell Harvesting System Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Cell Therapy Manufacturing Opportunity Analysis |
|
| Cell Harvesting Workflow Optimization Analysis |
|
| Bioprocess Automation Adoption Assessment |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of cell harvesting system?
How is the cell harvesting system industry size expected to evolve during the forecast period?
How is rising investment in regenerative medicine and biopharmaceutical R&D shaping demand for advanced cell harvesting systems?
What is driving increased clinical adoption of cell harvesting systems in response to chronic disease and stem cell therapy demand?
Why is Peripheral Blood the largest application segment in the cell harvesting system market?
Why are R&D Centers the fastest-growing end-use segment in the cell harvesting system market?
Why is North America the largest market for cell harvesting systems?
What is fueling cell harvesting system market growth in Asia Pacific?
Which companies dominate the cell harvesting system landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization